DE3685604D1 - 1,7-naphthyridinderivate und diese enthaltende arzneimittel. - Google Patents

1,7-naphthyridinderivate und diese enthaltende arzneimittel.

Info

Publication number
DE3685604D1
DE3685604D1 DE8686105069T DE3685604T DE3685604D1 DE 3685604 D1 DE3685604 D1 DE 3685604D1 DE 8686105069 T DE8686105069 T DE 8686105069T DE 3685604 T DE3685604 T DE 3685604T DE 3685604 D1 DE3685604 D1 DE 3685604D1
Authority
DE
Germany
Prior art keywords
products containing
medicinal products
naphthyridine derivatives
naphthyridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686105069T
Other languages
English (en)
Other versions
DE3685604T2 (de
Inventor
Susumu Sato
Haruyoshi Honda
Teruo Koumoto
Ltd Isomae
Tadayuki Kuraishi
Tatsuhiko Katori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of DE3685604D1 publication Critical patent/DE3685604D1/de
Publication of DE3685604T2 publication Critical patent/DE3685604T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8686105069T 1985-04-17 1986-04-14 1,7-naphthyridinderivate und diese enthaltende arzneimittel. Expired - Fee Related DE3685604T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8196785 1985-04-17

Publications (2)

Publication Number Publication Date
DE3685604D1 true DE3685604D1 (de) 1992-07-16
DE3685604T2 DE3685604T2 (de) 1993-01-28

Family

ID=13761269

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686105069T Expired - Fee Related DE3685604T2 (de) 1985-04-17 1986-04-14 1,7-naphthyridinderivate und diese enthaltende arzneimittel.

Country Status (5)

Country Link
US (2) US4659710A (de)
EP (1) EP0198456B1 (de)
JP (1) JPS6230780A (de)
CA (1) CA1256433A (de)
DE (1) DE3685604T2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6348277A (ja) * 1986-08-19 1988-02-29 Ss Pharmaceut Co Ltd ８−ピペラジニル−１，７−ナフチリジン誘導体
US5750529A (en) * 1991-07-03 1998-05-12 Otsuka Pharmaceutical Co., Ltd. Apoptosis regulating compostion
GB9622386D0 (en) * 1996-10-28 1997-01-08 Sandoz Ltd Organic compounds
US6020335A (en) * 1997-02-06 2000-02-01 Pfizer Inc (N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents
NZ523526A (en) * 2000-07-20 2004-10-29 Neurogen Corp Diaryl piperazines as capsaicin receptor ligands
WO2002049632A1 (fr) 2000-12-18 2002-06-27 Institute Of Medicinal Molecular Design. Inc. Inhibiteurs de production et de liberation de cytokines inflammatoires
DE10222895A1 (de) * 2002-05-23 2003-12-11 Bosch Gmbh Robert Hochdruckspeicher für Kraftstoffeinspritzsysteme mit integriertem Druckregelventil
EP1512396A4 (de) * 2002-06-05 2008-12-31 Inst Med Molecular Design Inc Hemmer gegen aktivierung von ap-1 und nfat
EP1510210A4 (de) * 2002-06-05 2009-01-07 Inst Med Molecular Design Inc Immunitätsbedingte proteinkinase-hemmer
EP1510207A4 (de) * 2002-06-05 2008-12-31 Inst Med Molecular Design Inc Therapeutisches arzneimittel gegen diabetes
EA009051B1 (ru) 2002-06-06 2007-10-26 Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. О-замещенные гидроксиарильные производные
JP4660674B2 (ja) * 2002-06-06 2011-03-30 株式会社医薬分子設計研究所 抗アレルギー薬
TW200307535A (en) * 2002-06-10 2003-12-16 Inst Med Molecular Design Inc Therapeutic agent for cancer
AU2003242098B2 (en) * 2002-06-10 2008-11-20 Institute Of Medicinal Molecular Design, Inc Inhibitors against activation of NFkappaB
AU2003242124A1 (en) * 2002-06-11 2003-12-22 Institute Of Medicinal Molecular Design, Inc. Medicament for treatment of neurodegenerative diseases
CN100417847C (zh) * 2002-11-12 2008-09-10 Nok株式会社 橡胶状弹性部件
JP4870164B2 (ja) * 2005-10-05 2012-02-08 エフ．ホフマン−ラ ロシュ アーゲー ナフチリジン誘導体
TW202104198A (zh) 2019-03-12 2021-02-01 美商賽堤爾醫療公司 Ｒａｄ５１抑制劑

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928367A (en) * 1969-04-14 1975-12-23 Schering Corp 1-Amino naphthyridines
US4017500A (en) * 1973-07-16 1977-04-12 Schering Corporation Certain 8-amino-1,7-naphthyridines
US4176183A (en) * 1977-05-02 1979-11-27 Merck & Co., Inc. Novel naphthyridines

Also Published As

Publication number Publication date
US4690924A (en) 1987-09-01
JPS6230780A (ja) 1987-02-09
EP0198456A2 (de) 1986-10-22
DE3685604T2 (de) 1993-01-28
EP0198456B1 (de) 1992-06-10
US4659710A (en) 1987-04-21
EP0198456A3 (en) 1988-02-03
JPH0428269B2 (de) 1992-05-13
CA1256433A (en) 1989-06-27

Similar Documents

Publication Publication Date Title
DE3676248D1 (de) Ubidecarenon enthaltende arzneimittel.
DE3780223D1 (de) Arzneimittel mit gesteuerter freisetzung.
DE10199018I2 (de) Thiazolidindion-Derivate, deren Herstellung und Anwendung.
DE3580616D1 (de) Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3689384D1 (de) Arzneimittel zur topischen Anwendung.
DE69014351D1 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
ATE124951T1 (de) Fluorcytidinderivate, deren herstellung und arzneimittel, die diese derivate enthalten.
DE69011059D1 (de) Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen.
DE3685604D1 (de) 1,7-naphthyridinderivate und diese enthaltende arzneimittel.
ATA285187A (de) Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel
DE3679920D1 (de) Spiro-3-heteroazolidinverbindungen und ihre salze, ihre herstellung und diese enthaltende pharmazeutische mittel.
IL80729A0 (en) Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
NL8601838A (nl) Distamycinederivaten, werkwijze voor de bereiding ervan, alsmede farmaceutische preparaten, die deze derivaten bevatten.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DE3481125D1 (de) Pheophorbidderivate und diese enthaltende pharmazeutische mittel.
IL84913A0 (en) Alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
DE68909501D1 (de) Hydroxyalkylcystein-derivate und diese enthaltende expectoranzien.
DE3672513D1 (de) 4,5,6,7-tetrahydro-2h-indazolderivate und diese enthaltende herbizide.
AT389119B (de) Pyrido(3,2,1-ij)-1,3,4-benzoxadiazinderivate und diese enthaltende pharmazeutische praeparate
DE3674017D1 (de) Oxalursaeure-derivate und pharmazeutisches mittel.
DE3678541D1 (de) N-vinylimidazole und -triazole und diese enthaltende arzneimittel.
DK578589A (da) Farmaceutisk praeparat indeholdende labdanterpenoidderivater og pyrimido(6,1-a)isoquinolin-4-onderivater, dets fremstilling og anvendelse
DE68919512D1 (de) Chinoxalin-Derivate und antiulzerierendes Mittel.
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
DE3676360D1 (de) Nitroderivate von vinblastintyp-bis-indolen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee